Progress in Medicinal Chemistry

Series Editor:

  • G. Lawton, St. Ippolyts, Herts, UK
  • David R. Witty, Convergence Pharmaceuticals Ltd, Cambridge, UK

Progress in Medicinal Chemistry provides a review of eclectic developments in medicinal chemistry. This volume continues in the serial's tradition of providing an insight into the skills required of the modern medicinal chemist; in particular, the use of an appropriate selection of the wide range of tools now available to solve key scientific problems.
View full description

Audience

Chemists, biologists, doctors, pharmacists and anyone interested in the contemporary controversy about drugs, drug firms, and the community

 

Book information

  • Published: May 2012
  • Imprint: ELSEVIER
  • ISBN: 978-0-12-396493-9


Table of Contents

  1. Small Molecule Bromodomain Inhibitors: Extending the Druggable Epigenome
  2. Chun-wa Chung

  3. TRPV1 Antagonists: Clinical Setbacks and Prospects for Future Development
  4. Michael E. Kort and Philip R. Kym

  5. Multivalent Dual Pharmacology Muscarinic Antagonist and β2 Agonist (MABA) Molecules for the Treatment of COPD
  6. Adam D. Hughes, Alexander McNamara and Tod Steinfeld

  7. Hematopoietic Prostaglandin D-Synthase Inhibitors

    Sukanthini Thurairatnam